| Name | Title | Contact Details |
|---|
Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.
Investment Consulting Group Inc is a Davenport, IA-based company in the Business Services sector.
National Builder Services Inc is a Orange, CA-based company in the Business Services sector.
Since 1992, D'Amico Catering has been the Twin Cities' premiere source for exceptional events. Whether it's an intimate dinner for 10 or a grand reception for 10,000, D'Amico Catering has the experience and talent to ensure that the affair is executed to
AlertStar Corporation is a Bellingham, WA-based company in the Business Services sector.